Literature DB >> 8632081

Guidelines of care for dermatomyositis. American Academy of Dermatology.

L A Drake1, S M Dinehart, E R Farmer, R W Goltz, G F Graham, M K Hordinsky, C W Lewis, D M Pariser, J W Skouge, S B Webster, D C Whitaker, B Butler, B J Lowery, R D Sontheimer, J P Callen, C Camisa, T T Provost, D L Tuffanelli.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8632081

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  18 in total

1.  Syndrome in question.

Authors:  Ana Cláudia Cavalcante Esposito; Tânia Munhoz; Juliana Polizel Ocanha; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2016 May-Jun       Impact factor: 1.896

2.  Refractory dermatomyositis-systemic lupus erythematosus overlap syndrome and response to tofacitinib.

Authors:  Preston Williams; Benjamin McKinney
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-09-28

3.  Dermatomyositis: analysis of 109 patients surveyed at the Hospital das Clínicas (HCFMUSP), São Paulo, Brazil.

Authors:  Luciena Cegatto Martins Ortigosa; Vitor Manuel Silva dos Reis
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

Review 4.  Amyopathic dermatomyositis.

Authors:  N J Olsen; J H Park; L E King
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

Review 5.  Recent Advances in Pharmacological Treatments of Adult Dermatomyositis.

Authors:  Kristen L Chen; Majid Zeidi; Victoria P Werth
Journal:  Curr Rheumatol Rep       Date:  2019-08-31       Impact factor: 4.592

Review 6.  Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.

Authors:  Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-12       Impact factor: 8.667

Review 7.  Corticosteroids in Myositis and Scleroderma.

Authors:  Anna Postolova; Jennifer K Chen; Lorinda Chung
Journal:  Rheum Dis Clin North Am       Date:  2015-10-26       Impact factor: 2.670

Review 8.  What is the background incidence of malignancy in children with rheumatic disease?

Authors:  Melissa L Mannion; Timothy Beukelman
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

9.  Rituximab as a glucocorticoid-sparing agent in idiopathic inflammatory myopathies: a retrospective single-center cohort study.

Authors:  Bugra Han Egeli; Sercan Ergun; Arya Cetin; Yahya Kerem Gursoy; Serdal Ugurlu
Journal:  Clin Rheumatol       Date:  2021-08-13       Impact factor: 2.980

10.  Clinical characteristics and outcomes of juvenile and adult dermatomyositis.

Authors:  Sang-Jun Na; Seung Min Kim; Il Nam Sunwoo; Young-Chul Choi
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.